- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Latest Conference Articles
PDA/FDA Joint Regulatory Conference: Product Quality Risk in Aging Facilities
September 11th 2024
During a presentation at the PDA/FDA Joint Regulatory Conference, Nicholas Violand of Johnson & Johnson and Paul Palmer of Paul R. Palmer Limited discussed how aging facilities can impact the quality of pharmaceutical products.
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
September 10th 2024
The 2024 CPHI Pharma Awards comprise finalists spanning 14 categories and includes awards for future leaders, women of the year, and an “at the heart of pharma” category.
PDA/FDA Joint Regulatory Conference: Proactive CAPA
September 9th 2024
CDER’s Jonathan Chapman, senior policy advisor, and Takeda’s Paulien Groll, head of Compliance Excellence, discussed how companies can be proactive with their CAPA strategies instead of reactive, at the 2024 PDA/FDA Joint Regulatory Conference.
Steriline to Show New Robotic Vial Filling and Capping Machine at CPHI Milan 2024
September 4th 2024
Among the design features of the machine is software-based tracking that is meant to ensure that products that are temperature-sensitive do not exceed their time limit in the solution.
A Discussion on the Outsourcing of mRNA Production (BIO 2024)
August 22nd 2024
Vernal Biosciences’ CEO and founder, Christian Cobaugh, discusses the outsourcing landscape for mRNA production.
AAPS PharmSci 360 2024: Developing Inhalation Drugs
August 21st 2024
For a preview of what's to come at the AAPS PharmSci 360 show in October, Pharmaceutical Technology® spoke with Vivek Gupta, PhD, associate dean for Graduate Education and Research, associate professor, Pharmaceutical Sciences, St. John’s University, Queens, New York, about the formulation of inhalation dosage forms.
Improving the Efficacy of Genetic Medicines
July 5th 2024
Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization
The Benefit of Long-Read Sequencing in Gene Therapies
June 18th 2024
Nadia Sellami, PhD, global segment lead for gene and cell therapy at PacBio, talks about long-read sequencing for cell and gene editing in a video interview.
Lamassu Pharma Bridges Scientific Knowledge and Patient Care
June 17th 2024
Gabi Hanna, MD, CEO and co-founder of Lamassu Pharma talks about a novel oncology platform and the link between science and patient care.
Pushing Boundaries to Revolutionize Chronic Inflammation Therapy
June 14th 2024
Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.